Cargando…
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497668/ https://www.ncbi.nlm.nih.gov/pubmed/28669140 http://dx.doi.org/10.3350/cmh.2017.0107 |
| _version_ | 1783248192372998144 |
|---|---|
| author | Kim, Do Young |
| author_facet | Kim, Do Young |
| author_sort | Kim, Do Young |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5497668 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | The Korean Association for the Study of the Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54976682017-07-05 Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? Kim, Do Young Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2017-06 2017-06-23 /pmc/articles/PMC5497668/ /pubmed/28669140 http://dx.doi.org/10.3350/cmh.2017.0107 Text en Copyright © 2017 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Do Young Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title_full | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title_fullStr | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title_full_unstemmed | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title_short | Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| title_sort | can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497668/ https://www.ncbi.nlm.nih.gov/pubmed/28669140 http://dx.doi.org/10.3350/cmh.2017.0107 |
| work_keys_str_mv | AT kimdoyoung canmetronomicchemotherapybeanalternativetosorafenibinadvancedhepatocellularcarcinoma |